242 related articles for article (PubMed ID: 34301927)
1. Stochastic pausing at latent HIV-1 promoters generates transcriptional bursting.
Tantale K; Garcia-Oliver E; Robert MC; L'Hostis A; Yang Y; Tsanov N; Topno R; Gostan T; Kozulic-Pirher A; Basu-Shrivastava M; Mukherjee K; Slaninova V; Andrau JC; Mueller F; Basyuk E; Radulescu O; Bertrand E
Nat Commun; 2021 Jul; 12(1):4503. PubMed ID: 34301927
[TBL] [Abstract][Full Text] [Related]
2. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
Chakraborty S; Kabi M; Ranga U
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
[TBL] [Abstract][Full Text] [Related]
3. Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.
Jadlowsky JK; Wong JY; Graham AC; Dobrowolski C; Devor RL; Adams MD; Fujinaga K; Karn J
Mol Cell Biol; 2014 Jun; 34(11):1911-28. PubMed ID: 24636995
[TBL] [Abstract][Full Text] [Related]
4. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
5. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
J Virol; 2018 May; 92(9):. PubMed ID: 29491162
[TBL] [Abstract][Full Text] [Related]
7. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
[TBL] [Abstract][Full Text] [Related]
8. Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.
Wilhelm E; Bell B
Curr Opin Virol; 2013 Aug; 3(4):380-6. PubMed ID: 23827503
[TBL] [Abstract][Full Text] [Related]
9. Nonlatching positive feedback enables robust bimodality by decoupling expression noise from the mean.
Razooky BS; Cao Y; Hansen MMK; Perelson AS; Simpson ML; Weinberger LS
PLoS Biol; 2017 Oct; 15(10):e2000841. PubMed ID: 29045398
[TBL] [Abstract][Full Text] [Related]
10. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
11. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
13. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
14. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
Li Z; Guo J; Wu Y; Zhou Q
Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
[TBL] [Abstract][Full Text] [Related]
15. Regulation of human immunodeficiency virus-1 latency and its reactivation.
Verdin E
Bull Mem Acad R Med Belg; 2008; 163(6):355-64; discussion 364-5. PubMed ID: 19445107
[TBL] [Abstract][Full Text] [Related]
16. HIV latency reversing agents act through Tat post translational modifications.
Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes.
Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X
FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458
[TBL] [Abstract][Full Text] [Related]
18. Lost in transcription: molecular mechanisms that control HIV latency.
Taube R; Peterlin M
Viruses; 2013 Mar; 5(3):902-27. PubMed ID: 23518577
[TBL] [Abstract][Full Text] [Related]
19. RNAP II processivity is a limiting step for HIV-1 transcription independent of orientation to and activity of endogenous neighboring promoters.
Kaczmarek Michaels K; Wolschendorf F; Schiralli Lester GM; Natarajan M; Kutsch O; Henderson AJ
Virology; 2015 Dec; 486():7-14. PubMed ID: 26379089
[TBL] [Abstract][Full Text] [Related]
20. Distinct promoter activation mechanisms modulate noise-driven HIV gene expression.
Chavali AK; Wong VC; Miller-Jensen K
Sci Rep; 2015 Dec; 5():17661. PubMed ID: 26666681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
